20% Off for 5+ Items
Starting now, ending on Dec. 31st, enjoy 20% discount on 5 or more items storewide.
Up to 10 - color IHC Detection Kits
High-plex targeted protein panels,Complete assay solution, automation ready, with ability to customize
New Products
Comprehensive assay kits for drug screening
Featured Products
20% off for 5+ items
Enjoy 20% discount on 5 or more items storewide including OneStep ELISA Kits, mIHC Kits, IHC antibodies, Organoid Culture Kits, PTMs antibodies and so on.
Promo Period: 1 July 2026 to 31 Dec 2026
New Semester Launch | Spacial Biology
Discount Code: ANT2608@20
Promotion valid from 15 Aug to 31 Oct, 2026
About Us
AntBio - Fueling Research, Feeding Discovery
AntBio is a biotechnology group company dedicated to serving life sciences, aiming to help scientists accelerate research and improve work efficiency. AntBio provides comprehensive and high-quality reagent tools for basic research, drug development, and diagnosis, including research grade antibodies, proteins, biochemical reagents, and assay kits. These research tools are widely used in different segments of life science research. The group company currently consists of three brands, Absin, Starter-Bio and UA-Bio.
50k
Happy Clients
100k
Products
70+
Doctor/Expert
20+
Life Science Experience
ARTICLES
Latest News
Anti‑Idiotypic Antibodies: ...
Idiotypic‑Network Theory: Immunological Foundation of Anti‑Idiotypic Antibody Biology The idiotypic‑network hypothesis proposed by immunologist Niels Jerne builds the conceptual foundation for interpreting anti‑idiotypic‑antibody biological behaviours. When foreign antigen stimulation drives...
Anti‑Idiotypic Antibodies: ...
Idiotypic‑Network Theory: Immunological Foundation of Anti‑Idiotypic Antibody Biology The idiotypic‑network hypothesis proposed by immunologist Niels Jerne builds the conceptual foundation...
View Details
Human IL‑28A (IFN‑λ2): Mechanistic In...
This immun‑oncology review explains type‑III interferon IL‑28A (IFN‑λ2) receptor‑restricted expression, JAK‑STAT signalling, multi‑cell‑mediated anti‑tumour immune mechanisms, comparative advantages versus type‑I IFN and pre‑clinical research bottlenecks. It lists human/mouse recombinant IL‑28A...
Human IL‑28A (IFN‑λ2): Mechanistic In...
This immun‑oncology review explains type‑III interferon IL‑28A (IFN‑λ2) receptor‑restricted expression, JAK‑STAT signalling, multi‑cell‑mediated anti‑tumour immune mechanisms, comparative advantages versus type‑I...
View Details
Achieving Precise Custom‑Development ...
This antibody‑engineering technical article covers end‑to‑end precise custom protein‑antibody development workflows, immunogen preparation, immunization schemes, multi‑dimensional specificity‑affinity validation, major technical bottlenecks and next‑generation recombinant‑antibody trends. It introduces full‑chain custom‑antibody development...
Achieving Precise Custom‑Development ...
This antibody‑engineering technical article covers end‑to‑end precise custom protein‑antibody development workflows, immunogen preparation, immunization schemes, multi‑dimensional specificity‑affinity validation, major technical...
View Details
Achieving High‑Throughput and High‑Se...
This bioprocess‑analytical review covers high‑throughput high‑sensitivity biotherapeutic residual impurity detection, ELISA and qPCR core principles, key assay‑performance‑evaluation metrics, prevalent technical bottlenecks and emerging technical evolution directions. It introduces biotherapeutic residual‑detection...
Achieving High‑Throughput and High‑Se...
This bioprocess‑analytical review covers high‑throughput high‑sensitivity biotherapeutic residual impurity detection, ELISA and qPCR core principles, key assay‑performance‑evaluation metrics, prevalent technical...
View Details